Analyst Consensus ?
ConsensusBuy45 ratings
Bullish2760.0%
Neutral1635.6%
Bearish24.4%
FN2 Earnings Intelligence
CSX Corporation complete analyst coverage
CSX Corporation (CSX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$50.84Current
$25Low
$44.29Average
$105High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Jul 24, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 23, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 23, 2026 |
| Benchmark | Buy | Buy | Maintain | Jul 15, 2026 |
| Susquehanna | Positive | Neutral | Upgrade | Jul 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 8, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 7, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 6, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 23, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Mar 31, 2026 |
| UBS | Buy | Buy | Maintain | Oct 17, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Jefferies | Buy | Buy | Maintain | Oct 17, 2025 |
| Stifel | Buy | Buy | Maintain | Apr 17, 2025 |
| Loop Capital | Hold | Buy | Downgrade | Feb 3, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jan 24, 2025 |
| Argus Research | Buy | Buy | Maintain | Jul 25, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 21, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jan 26, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 29, 2022 |
| TD Securities | Hold | Buy | Downgrade | Apr 18, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Sep 23, 2020 |
| CFRA | Buy | Buy | Maintain | Apr 23, 2020 |
| Bank of America | Buy | Buy | Maintain | Oct 17, 2019 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Mar 6, 2019 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Scotiabank | Sector Perform | Sector Outperform | Downgrade | Jan 12, 2018 |
| Avondale Partners | Outperform | Market Outperform | Maintain | Feb 10, 2017 |
| Aegis Capital | Hold | Hold | Maintain | Oct 24, 2016 |
| Seaport Global | Neutral | Neutral | Maintain | Oct 19, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Jul 15, 2016 |
| Oppenheimer | Perform | Market Perform | Maintain | Jun 16, 2016 |
| CLSA | Underperform | Underperform | Maintain | May 19, 2016 |
| Nomura | Buy | Buy | Maintain | Jan 14, 2016 |
| Buckingham Research | Buy | Buy | Maintain | Jan 14, 2016 |
| Topeka | Hold | Hold | Maintain | Jul 10, 2015 |
| Macquarie | Neutral | Neutral | Maintain | Aug 12, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Jun 24, 2014 |
| Sterne Agee | Buy | Buy | Maintain | Apr 19, 2012 |
| Bank oferica | Buy | Buy | Maintain | Mar 15, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $50.84. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $59 | $53.2 | +16.1% | Jul 24, 2026 |
| RBC Capital | Walter Spracklin | $54 | $52.68 | +6.2% | Jul 23, 2026 |
| Stifel Nicolaus | Analyst unavailable | $54 | $52.68 | +6.2% | Jul 23, 2026 |
| BMO Capital | Analyst unavailable | $52 | $52.11 | +2.3% | Jul 23, 2026 |
| Evercore ISI | Analyst unavailable | $51 | $52.42 | +0.3% | Jul 23, 2026 |
| Barclays | Analyst unavailable | $60 | $49.93 | +18.0% | Jul 23, 2026 |
| Susquehanna | Analyst unavailable | $58 | $49.64 | +14.1% | Jul 14, 2026 |
| Raymond James | Analyst unavailable | $56 | $49.8 | +10.1% | Jul 13, 2026 |
| Truist Financial | Analyst unavailable | $46 | $49.56 | -9.5% | Jul 10, 2026 |
| Robert W. Baird | Daniel Moore | $53 | $48.81 | +4.2% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $32 | $49.12 | -37.1% | Jul 6, 2026 |
| Barclays | Brandon Oglenski | $55 | $46.06 | +8.2% | Jun 25, 2026 |
| Evercore ISI | Analyst unavailable | $47 | $46.06 | -7.6% | Jun 25, 2026 |
| RBC Capital | Analyst unavailable | $51 | $46.68 | +0.3% | Jun 24, 2026 |
| Wells Fargo | Analyst unavailable | $53 | $46.9 | +4.2% | Jun 17, 2026 |
| Susquehanna | Analyst unavailable | $50 | $46.99 | -1.7% | Jun 5, 2026 |
| Evercore ISI | Analyst unavailable | $46 | $44.84 | -9.5% | May 11, 2026 |
| Robert W. Baird | Analyst unavailable | $47 | $46.18 | -7.6% | Apr 24, 2026 |
| Wolfe Research | Analyst unavailable | $50 | $46.44 | -1.7% | Apr 23, 2026 |
| RBC Capital | Walter Spracklin | $47 | $45.99 | -7.6% | Apr 23, 2026 |
| BMO Capital | Analyst unavailable | $45 | $43.18 | -11.5% | Apr 23, 2026 |
| New Street | Analyst unavailable | $49 | $43.18 | -3.6% | Apr 23, 2026 |
| Barclays | Analyst unavailable | $47 | $43.18 | -7.6% | Apr 23, 2026 |
| Goldman Sachs | Analyst unavailable | $41 | $43.18 | -19.4% | Apr 23, 2026 |
| Vertical Research | Analyst unavailable | $44 | $43.18 | -13.5% | Apr 23, 2026 |
| Raymond James | Analyst unavailable | $45 | $42.51 | -11.5% | Apr 15, 2026 |
| RBC Capital | Analyst unavailable | $43 | $39.55 | -15.4% | Mar 26, 2026 |
| Susquehanna | Analyst unavailable | $39 | $37.34 | -23.3% | Jan 23, 2026 |
| Evercore ISI | Analyst unavailable | $40 | $37.36 | -21.3% | Jan 23, 2026 |
| Bernstein | David Vernon | $36 | $35.78 | -29.2% | Jan 23, 2026 |
| RBC Capital | Walter Spracklin | $40 | $36.63 | -21.3% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $30 | $36.3 | -41.0% | Dec 8, 2025 |
| Robert W. Baird | Analyst unavailable | $40 | $36.6 | -21.3% | Oct 20, 2025 |
| Jefferies | Stephanie Moore | $42 | $37.02 | -17.4% | Oct 17, 2025 |
| Evercore ISI | Q3 EPS | $39 | $35.99 | -23.3% | Oct 17, 2025 |
| UBS | Thomas Wadewitz | $45 | $35.99 | -11.5% | Oct 17, 2025 |
| Susquehanna | Analyst unavailable | $34 | $33.78 | -33.1% | Sep 25, 2025 |
| Wells Fargo | Christian Wetherbee | $40 | $33.82 | -21.3% | Sep 25, 2025 |
| RBC Capital | Analyst unavailable | $39 | $32.75 | -23.3% | Sep 18, 2025 |
| Robert W. Baird | Daniel Moore | $44 | $35.76 | -13.5% | Jul 25, 2025 |
| Argus Research | Analyst unavailable | $32 | $27.84 | -37.1% | Apr 25, 2025 |
| Susquehanna | Bascome Majors | $37 | $29.92 | -27.2% | Mar 27, 2025 |
| Deutsche Bank | Analyst unavailable | $34 | $31.26 | -33.1% | Mar 7, 2025 |
| Loop Capital Markets | Rick Paterson | $34 | $32.51 | -33.1% | Feb 3, 2025 |
| RBC Capital | Walter Spracklin | $35 | $35.47 | -31.2% | Oct 17, 2024 |
| Wells Fargo | Christian Wetherbee | $34 | $35.47 | -33.1% | Oct 17, 2024 |
| Jefferies | Stephanie Moore | $37 | $35.47 | -27.2% | Oct 17, 2024 |
| BMO Capital | Fadi Chamoun | $39 | $35.47 | -23.3% | Oct 17, 2024 |
| Evercore ISI | Jonathan Chappell | $37 | $35.47 | -27.2% | Oct 17, 2024 |
| Citigroup | Ariel Rosa | $41 | $35.47 | -19.4% | Oct 17, 2024 |
| Susquehanna | Bascome Majors | $42 | $34.52 | -17.4% | Oct 2, 2024 |
| Barclays | Brandon Oglenski | $40 | $34.14 | -21.3% | Sep 25, 2024 |
| Wolfe Research | Scott Group | $38 | $33.69 | -25.3% | Aug 23, 2024 |
| Stephens | Daniel Imbro | $42 | $33.3 | -17.4% | Jul 8, 2024 |
| Robert W. Baird | Garrett Holland | $39 | $34.46 | -23.3% | Apr 18, 2024 |
| BMO Capital | Fadi Chamoun | $40 | $34.24 | -21.3% | Apr 18, 2024 |
| UBS | Thomas Wadewitz | $44 | $34.16 | -13.5% | Apr 18, 2024 |
| RBC Capital | Walter Spracklin | $36 | $34.16 | -29.2% | Apr 18, 2024 |
| Jefferies | Stephanie Moore | $38 | $34.16 | -25.3% | Apr 18, 2024 |
| Jefferies | Stephanie Moore | $40 | $36.3 | -21.3% | Apr 8, 2024 |
| Wolfe Research | Chris Caso | $105 | $34.55 | +106.5% | Jan 22, 2024 |
| J.P. Morgan | Brian Ossenbeck | $40 | $30.87 | -21.3% | Oct 19, 2023 |
| BMO Capital | Fadi Chamoun | $37 | $33.71 | -27.2% | Jul 21, 2023 |
| Morgan Stanley | Analyst unavailable | $24 | $32.24 | -52.8% | Jan 11, 2023 |
| Wells Fargo | Analyst unavailable | $32 | $31 | -37.1% | Jan 4, 2023 |
| Barclays | Analyst unavailable | $38 | $31.7 | -25.3% | Nov 29, 2022 |
| Deutsche Bank | Analyst unavailable | $39 | $31.7 | -23.3% | Nov 29, 2022 |
| Morgan Stanley | Analyst unavailable | $23 | $27.34 | -54.8% | Oct 3, 2022 |
| Barclays | Analyst unavailable | $35 | $27.19 | -31.2% | Sep 30, 2022 |
| Citigroup | Analyst unavailable | $30 | $26.98 | -41.0% | Sep 29, 2022 |
| Bernstein | David Vernon | $32 | $31.23 | -37.1% | Sep 14, 2022 |
| Credit Suisse | Ariel Rosa | $37 | $30.99 | -27.2% | Jul 21, 2022 |
| Cowen & Co. | Analyst unavailable | $37 | $30.9 | -27.2% | Jul 21, 2022 |
| Barclays | Analyst unavailable | $40 | $31.04 | -21.3% | Jul 21, 2022 |
| Stephens | Analyst unavailable | $35 | $31.07 | -31.2% | Jul 21, 2022 |
| Susquehanna | Analyst unavailable | $35 | $29.73 | -31.2% | Jul 21, 2022 |
| Loop Capital Markets | Rick Paterson | $38 | $29.73 | -25.3% | Jul 21, 2022 |
| Wells Fargo | Analyst unavailable | $30 | $28.18 | -41.0% | Jul 15, 2022 |
| Stifel Nicolaus | Benjamin Nolan | $37 | $28.18 | -27.2% | Jul 15, 2022 |
| Barclays | Analyst unavailable | $39 | $28.17 | -23.3% | Jul 13, 2022 |
| J.P. Morgan | Analyst unavailable | $33 | $28.42 | -35.1% | Jul 12, 2022 |
| Credit Suisse | Ariel Rosa | $35 | $28.99 | -31.2% | Jul 11, 2022 |
| Raymond James | Analyst unavailable | $35 | $29.03 | -31.2% | Jul 8, 2022 |
| Susquehanna | Analyst unavailable | $36 | $28.74 | -29.2% | Jul 6, 2022 |
| Susquehanna | Analyst unavailable | $45 | $36.93 | -11.5% | Apr 21, 2022 |
| Raymond James | Analyst unavailable | $40 | $35.3 | -21.3% | Apr 21, 2022 |
| Bank of America Securities | Ken Hoexter | $38 | $35.06 | -25.3% | Apr 18, 2022 |
| Morgan Stanley | Ravi Shanker | $25 | $34 | -50.8% | Jan 21, 2022 |
| Stephens | Justin Long | $41 | $34 | -19.4% | Jan 21, 2022 |
| Wolfe Research | Scott Group | $40 | $34 | -21.3% | Jan 21, 2022 |
| J.P. Morgan | Brian Ossenbeck | $39 | $36.53 | -23.3% | Jan 12, 2022 |
| Benchmark Co. | Mark Levin | $41 | $36.19 | -19.4% | Jan 11, 2022 |
| Citigroup | Christian Wetherbee | $45 | $37.33 | -11.5% | Jan 5, 2022 |
| UBS | Thomas Wadewitz | $42 | $36.36 | -17.4% | Dec 15, 2021 |
| BMO Capital | Fadi Chamoun | $41 | $35.81 | -19.4% | Dec 14, 2021 |
| Goldman Sachs | Jordan Alliger | $38 | $34.81 | -25.3% | Oct 21, 2021 |
| Barclays | Brandon Oglenski | $41 | $34.81 | -19.4% | Oct 21, 2021 |
| Stifel Nicolaus | Benjamin Nolan | $39 | $34.81 | -23.3% | Oct 21, 2021 |
| TD Securities | Cherilyn Radbourne | $38 | $32.4 | -25.3% | Jul 22, 2021 |
Track every rating change on CSX the moment it posts. Free to start.
Start free